{"product_id":"medical-care-of-the-liver-transplant-patient-isbn-9781444335910","title":"Medical Care of the Liver Transplant Patient","description":"This book builds on the success of previous editions, once again providing hepatologists the most current clinical guide on how to best treat the liver transplant recipient. With an international mix of experienced contributors, this new edition highlights initial indication and selection of the potential recipient, management of the donor organ, post-operative complications in the patient through to acute recovery, long-term follow-up, and continued health. This provides the user a complete guide to the correct clinical management of both the recipient and the donor organ through all stages of transplantation.  Contributors, ix  \u003cp\u003ePreface, xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 Management of the potential transplant recipient\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 Selection and evaluation of the recipient (including retransplantation), 3\u003cbr\u003e \u003ci\u003eAudrey Coilly and Didier Samuel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 Monitoring the patient awaiting liver transplantation, 13\u003cbr\u003e \u003ci\u003eAndreas Geier and Beat Müllhaupt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Management of portal hypertension, 26\u003cbr\u003e \u003ci\u003eJuan Carlos Garcia-Pagan, Juan G. Abraldes and Jaime Bosch\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Management of renal disease in the liver transplant candidate, 39\u003cbr\u003e \u003ci\u003eAndrés Cárdenas and Pere Ginès\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Management of hepatopulmonary syndrome and portopulmonary hypertension, 51\u003cbr\u003e \u003ci\u003eVictor I. Machicao and Michael B. Fallon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Psychiatric and substance abuse evaluation of the potential liver transplant recipient, 62\u003cbr\u003e \u003ci\u003eThomas P. Beresford\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Organ allocation in liver transplantation: ethics, organ supply, and evidencebased practice, 75\u003cbr\u003e \u003ci\u003eNicole Siparsky, David Axelrod and Richard B. Freeman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 Viral hepatitis and transplantation, 88\u003cbr\u003e \u003ci\u003eGeoffrey W. McCaughan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Metabolic liver diseases, 97\u003cbr\u003e \u003ci\u003eMaureen M.J. Guichelaar and Michael R. Charlton\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Cholestatic and autoimmune liver disease, 110\u003cbr\u003e \u003ci\u003eUlrich Beuers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Hepatocellular carcinoma, 121\u003cbr\u003e \u003ci\u003eMaria Reig, Alejandro Forner and Jordi Bruix\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Cholangiocarcinoma, 133\u003cbr\u003e \u003ci\u003eHoward C. Masuoka, Gregory J. Gores and Charles B. Rosen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Rare indications for liver transplantation, 145\u003cbr\u003e \u003ci\u003eStevan A. Gonzalez\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Liver transplantation in HIV patients, 155\u003cbr\u003e \u003ci\u003eMarion G. Peters and Peter G. Stock\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Living-donor liver transplantation, 162\u003cbr\u003e \u003ci\u003eRobert S. Brown Jr\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Fulminant hepatic failure, 176\u003cbr\u003e \u003ci\u003eMichael A. Heneghan and William Bernal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Donor issues and management in the perioperative period\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e17 Extended-criteria donor, 191\u003cbr\u003e \u003ci\u003eAshraf Mohammad El-Badry and Mickael Lesurtel\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Liver transplantation using donors after cardiac death, 201\u003cbr\u003e \u003ci\u003ePaolo Muiesan, Laura Tariciotti and Chiara Rocha\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Transmission of malignancies and infection through donor organs, 216\u003cbr\u003e \u003ci\u003eAaron M. Winnick and Lewis Teperman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 The transplant operation, 229\u003cbr\u003e \u003ci\u003ePhilipp Dutkowski, Olivier de Rougemont and Pierre-Alain Clavien\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Difficult surgical patients, 238\u003cbr\u003e \u003ci\u003ePhilipp Dutkowski, Stefan Breitenstein and Pierre-Alain Clavien\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Domino and split-liver transplantation, 246\u003cbr\u003e \u003ci\u003eAbhideep Chaudhary and Abhinav Humar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Surgical aspects of living-donor transplantation, 255\u003cbr\u003e \u003ci\u003eKelvin K.C. Ng and Sheung Tat Fan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Anesthesia, 266\u003cbr\u003e \u003ci\u003eBeatrice Beck-Schimmer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Coagulation and blood transfusion management, 276\u003cbr\u003e \u003ci\u003eHerman G.D. Hendriks, Ton Lisman and Robert J. Porte\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Critical care of the liver transplant recipient, 286\u003cbr\u003e \u003ci\u003eMarkus Béchir, Erik Schadde and Philipp Dutkowski\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Rejection and immunosuppression trends in liver transplantation, 297\u003cbr\u003e \u003ci\u003eJames F. Trotter\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Vascular complications after liver transplantation, 311\u003cbr\u003e \u003ci\u003eGoran Klintmalm and Srinath Chinnakotla\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Biliary complications following liver transplantation, 319\u003cbr\u003e \u003ci\u003eSanna op den Dries, Robert C. Verdonk and Robert J. Porte\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Role of histopathology, 332\u003cbr\u003e \u003ci\u003eAchim Weber\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Chronic problems in the transplant recipient\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e31 Medical problems after liver transplantation, 347\u003cbr\u003e \u003ci\u003eEberhard L. Renner and Marco Puglia\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Prevention and treatment of recurrent HBV and HCV infection, 361\u003cbr\u003e \u003ci\u003eEd Gane\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Recurrence of the original disease, 372\u003cbr\u003e \u003ci\u003eJames Neuberger\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Infections in the liver transplant recipient, 380\u003cbr\u003e \u003ci\u003eNicolas J. Mueller and Jay A. Fishman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Cutaneous diseases in liver transplant recipients, 389\u003cbr\u003e \u003ci\u003eSylvie Euvrard and Jean Kanitakis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Post-transplant lymphoproliferative disorder and other malignancies after liver transplantation, 398\u003cbr\u003e \u003ci\u003eNatasha Chandok and Kymberly D.S. Watt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Sexual function and fertility after liver transplantation, 406\u003cbr\u003e \u003ci\u003eAndreas Geier and Beat Müllhaupt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Pediatric liver transplantation\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e38 Special considerations in pediatric liver transplantation, 419\u003cbr\u003e \u003ci\u003eBrandy Ries Lu and Ronald J. Sokol\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eMultiple choice questions, 431\u003c\/p\u003e \u003cp\u003eAnswers, 446\u003c\/p\u003e \u003cp\u003eIndex, 451\u003c\/p\u003e  \u003cp\u003e“I can recommend the book with enthusiasm. It will find a place on my bookshelf.”  (\u003ci\u003eGastroenterology\u003c\/i\u003e, 1 December 2012)\u003c\/p\u003e \u003cp\u003e“This new edition does a good job addressing more current issues in liver transplantation. It succinctly provides an excellent base of understanding, guiding readers through a variety of indications for liver transplantation to help them understand the operative and chronic management of these patients.”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 20 July 2012)\u003c\/p\u003e \u003cp\u003e \u003c\/p\u003e  \u003cb\u003ePierre-Alain Clavien\u003c\/b\u003e, MD, PhD, FACS, FRCS (Eng), FRCS (Ed), Professor and Chairman, Department of Surgery. Head, Division of Visceral \u0026amp; Transplantation Surgery, University Hospital Zurich, Switzerland\u003cbr\u003e Professor Clavien is a world-wide renowned surgeon-scientist, currently professor and chairman of the Department of Surgery in Zurich, Switzerland. His areas of research include organ preservation, liver ischemia-reperfusion injury and regeneration, and pathogenesis of cancer, as well as outcome research. He received many competitive grants and awards, including one of the most prestigious prices for scientific research, the Otto Naegeli Award.  \u003cp\u003e\u003cb\u003eDr James Trotter\u003c\/b\u003e is the Medical Director of Liver Transplantation at Baylor University Medical Center at Dallas. Dr. Trotter's primary interests include end-stage liver disease and the management of liver transplant candidates and recipients. Dr. Trotter specializes in hepatitis C, ascites, complications of portal hypertension, including esophageal varices and hepatic encephalopathy. He also has vast experience in the management of medical complications after liver transplantation including immunosuppression in liver transplant recipients and the treatment of hepatitis C before and after liver transplantation.\u003c\/p\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47989600944357,"sku":"NP9781444335910","price":221.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781444335910.jpg?v=1761784762","url":"https:\/\/k12savings.com\/es\/products\/medical-care-of-the-liver-transplant-patient-isbn-9781444335910","provider":"K12savings","version":"1.0","type":"link"}